Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Psoriasis”

Showing 20 of 0 results

Not applicableEnded earlyNCT00795353
What this trial is testing

Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Astellas Pharma Inc 64
Testing effectiveness (Phase 2)Study completedNCT02949388
What this trial is testing

Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Stable Plaque Psoriasis
Innovation Pharmaceuticals, Inc. 199
Testing effectiveness (Phase 2)Study completedNCT06972888
What this trial is testing

A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Accro Bioscience (Suzhou) Limited 145
Early research (Phase 1)UnknownNCT05258331
What this trial is testing

Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
GC Cell Corporation 24
Large-scale testing (Phase 3)Study completedNCT01729754
What this trial is testing

Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011)

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries Limited 1,090
Post-approval studies (Phase 4)Study completedNCT04914429
What this trial is testing

Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 327
Large-scale testing (Phase 3)Study completedNCT04607980
What this trial is testing

Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Amgen 563
Post-approval studies (Phase 4)Study completedNCT00733954
What this trial is testing

Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Galderma R&D 250
Not applicableStudy completedNCT06106230
What this trial is testing

Bee Venom Phonophoresis on Mild to Moderate Localized Plaque Psoriasis on Knee Joint

Who this might be right for
Plaque Psoriasis
MTI University 100
Large-scale testing (Phase 3)Study completedNCT02326272
What this trial is testing

Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

Who this might be right for
PsoriasisPlaque Psoriasis
UCB Biopharma S.P.R.L. 227
Post-approval studies (Phase 4)UnknownNCT01443338
What this trial is testing

Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2

Who this might be right for
Psoriasis Vulgaris
Ministry of Health, China 720
Large-scale testing (Phase 3)Ended earlyNCT01708603
What this trial is testing

P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Bausch Health Americas, Inc. 1,831
Large-scale testing (Phase 3)Study completedNCT02326298
What this trial is testing

An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

Who this might be right for
PsoriasisPlaque Psoriasis
UCB Biopharma S.P.R.L. 234
Testing effectiveness (Phase 2)Study completedNCT00773734
What this trial is testing

Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)

Who this might be right for
PsoriasisPlaque-type Psoriasis
Amgen 352
Large-scale testing (Phase 3)Looking for participantsNCT06842199
What this trial is testing

Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis Patients
Beijing InnoCare Pharma Tech Co., Ltd. 383
Testing effectiveness (Phase 2)Study completedNCT00601107
What this trial is testing

Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Genzyme, a Sanofi Company 111
Not applicableStudy completedNCT03167515
What this trial is testing

Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Ferndale Laboratories, Inc. 95
Testing effectiveness (Phase 2)Study completedNCT02933528
What this trial is testing

Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 24
Not applicableStudy completedNCT02489643
What this trial is testing

Individualized Medical Training and Calcipotriol and Betamethasone Dipropionate Gel in Plaque Psoriasis

Who this might be right for
Psoriasis
Catholic University of the Sacred Heart 60
Early research (Phase 1)Study completedNCT05504317
What this trial is testing

AK111 in Subjects With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Psoriasis
Akeso 48
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation